Continuous wound infusion of local anesthetic and steroid after major abdominal surgery: study protocol for a randomized controlled trial
Authors:
- Dario BugadaDBDario Bugada
- Manuela De GregoriMGManuela De Gregori
- Christian CompagnoneCCChristian Compagnone
- Carolina MuscoliCMCarolina Muscoli
- Ferdinando RaimondiFRFerdinando Raimondi
- Silvia BettinelliSBSilvia Bettinelli
- Maria Antonietta AvanziniMAMaria Antonietta Avanzini
- Lorenzo CobianchiLCLorenzo Cobianchi
- Andrea PelosoAPAndrea Peloso
- Marco BaciarelloMBMarco Baciarello
- Concetta DagostinoCDConcetta Dagostino
- Luigino A. GiancottiLGLuigino A. Giancotti
Open Access
- 14 August 2015
- journal article
- clinical trial
- Published by Springer Nature in Trials
- Vol. 16 (1) , 1-9
Abstract
Inflammatory response is one of the key components of pain perception. Continuous infusion (CWI) of local anesthetics has been shown to be effective in controlling pain and reducing postoperative morphine consumption, but the effect of adding a potent anti-inflammatory drug (such as a steroid) has never been addressed. In our study, we want to investigate the effect of CWI with local anesthetic + methylprednisolone on acute and persistent pain, correlating clinical data with biomarkers of inflammation and genetic background. After approval by their institutional review board, three hospitals will enroll 120 patients undergoing major abdominal surgery in a randomized, double-blind, phase III study. After a 24-h CWI of ropivacaine 0.2 % + methylprednisolone 1 mg/kg, patients will be randomly assigned to receive either ropivacaine + steroid or placebo for the next 24 h. Then, patient-controlled CWI with only ropivacaine 0.2 % or placebo (according to the group of randomization) is planned after 48 h up to 7 days (bolus 10 ml, lock-out 1 h, maximum dose of 40 ml in 4 h). Morphine equivalent consumption up to 7 days will be analyzed, together with any catheter- or drug-related side effect. Persistent post-surgical pain (PPSP) incidence will also be investigated. Our primary endpoint is analgesic consumption in the first 7 days after surgery; we will evaluate, as secondary endpoints, any catheter- or drug-related side effect, genotype/phenotype correlations between some polymorphisms and postoperative outcome in terms of morphine consumption, development of the inflammatory response, and incidence of PPSP. Finally, we will collect, in a subgroup of patients, wound exudate samples by micro-dialysis, blood samples, and urine samples up to 72 h to investigate local and systemic inflammation and oxidative stress. This is a phase III trial to evaluate the safety and efficacy of wound infusion with steroid and local anesthetic. The study is aimed also to evaluate how long this infusion has to be maintained in order to maximize effectiveness. Our data are intended to quantify the amount of ropivacaine and methylprednisolone needed by patients undergoing major abdominal surgery, to be stored in a new nanotechnology device for sustained pain treatment after surgery. We also aim to clarify the roles of inflammatory response, oxidative stress, and genetic background on postoperative and persistent pain after major abdominal surgery. The trial was registered on ClinicalTrials.gov (NCT02002663) on 24 Oct. 2013.Keywords
This publication has 34 references indexed in Scilit:
- Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancerJournal of Clinical Anesthesia, 2014
- Acute and chronic pain: Where we are and where we have to go. 4th SIMPAREuropean journal of pain, 2011
- How regional analgesia might reduce postoperative cancer recurrenceEuropean journal of pain, 2011
- The progression from acute to chronic painCurrent Opinion in Anaesthesiology, 2011
- New Concepts in Acute Pain Management: Strategies to Prevent Chronic Postsurgical Pain, Opioid-Induced Hyperalgesia, and Outcome MeasuresAnesthesiology Clinics, 2011
- Dissecting post-herniotomy pain – Scratching the surface?Pain, 2010
- Pain related sexual dysfunction after inguinal herniorrhaphyPain, 2006
- Pain and functional impairment 6 years after inguinal herniorrhaphyHernia, 2006
- Persistent postsurgical pain: risk factors and preventionThe Lancet, 2006
- Chronic Pain as an Outcome of SurgeryAnesthesiology, 2000